Blackstone's $1.2B Defense Bet, Together AI's $800M & the AI Agent Layer
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Blackstone's $1.2B Defense Bet, Together AI's $800M & the AI Agent Layer
-
ナレーター：
-
著者：
(00:01:03) Dominion Dynamics Canadian Defense Play
(00:01:32) Together AI GPU Neocloud Eight Hundred Million
(00:02:17) AIsa AI Agent Transaction Layer
(00:02:55) Straiker Agentic Security Category
(00:03:18) FinTech and Biotech Signals
(00:04:00) Key Watchpoints This Cycle
This episode covers the week's most consequential funding and market structure stories across defense tech, AI infrastructure, and agentic AI — with signals that matter for founders, investors, and operators.
The headline is Blackstone leading a $1.2B Series D into Quantum Systems, a German defense drone company, at an $8B valuation. Co-investors include Airbus, Fidelity, and Wellington. The round marks a structural shift: European defense tech is no longer a niche venture bet — it's an institutional asset class anchored by PE and sovereign wealth. Canada is following the same logic, with Dominion Dynamics raising $100M for drone and command-and-control software, backed by Georgian, Bessemer, Lakestar, and Valor Equity.
Away from defense, Together AI closed $800M at an $8.3B valuation from Aramco Ventures, Vista Equity, General Catalyst, and NVIDIA — validating the GPU neocloud thesis and enterprise demand for alternatives to hyperscaler lock-in.
Two smaller but structurally significant rounds round out the picture. AIsa raised $65M Series A for a financial and API layer purpose-built for autonomous AI agents — 20,000 agents onboarded without paid marketing. Straiker raised $64M to secure enterprises from agentic AI threats, with 15x run-rate revenue growth in under a year.
Fintech and biotech close out the episode: inKind secured $320M in structured debt, Quantifind raised $200M for AI-native financial crime detection, and Celea Therapeutics raised $180M for a Phase Three antifibrotic trial backed by RA Capital and Leaps by Bayer.
Two watchpoints for the cycle ahead: whether Blackstone's defense move triggers a broader PE wave in Europe, and whether agentic AI infrastructure startups can prove unit economics at scale.
This episode includes AI-generated content.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません